Biopharma Deals Offer Hope for Future Public Listings Investors are cautiously optimistic that the sector’s long drought could be coming to an end. Stephen Taub March 27, 2023
This content is from: Premium The Complete Rich List: The 22nd Annual Ranking of the Highest-Earning Hedge Fund Managers Stephen Taub March 07, 2023
This content is from: Premium ETFs: An Indispensable Tool for Rising Volatility Sponsored by iShares March 09, 2023
Nvidia Surge Boosts Hedge Funds Almost 200 funds now have positions in the high-flying chipmaker, which is up 142 percent since October. Stephen Taub March 24, 2023
Big One-Day Gains for GameStop and Carvana Few hedge funds remain in the two controversial stocks, which caused so much pain for several funds two years ago. Stephen Taub March 23, 2023
Lion Point Reaches Surprise Deal with Semtech The activist hadn’t disclosed its investment in the semiconductor company before it reached the settlement. Stephen Taub March 22, 2023
A Rising Tide in Thematic ETFs Institutional investors eye a wave of opportunity. Sponsored by iShares February 23, 2023
Institutional Investors More Than Doubled Their Hedge Fund Allocations Last Year Here’s a look at last year’s biggest allocators — and the top hedge fund recipients. Stephen Taub March 21, 2023
EJF Capital’s Nightmare Here’s how the financials-oriented firm is coping with the bank stock selloff. Stephen Taub March 20, 2023
Seligman’s Wick Predicted the Tech Rally The manager who enjoyed a profitable 2022 singles out seven companies with low valuations. Stephen Taub March 17, 2023
Sponsored Alternative Opportunities Amid Rising Rates Hedge funds might solve for the inefficacy of traditional portfolio construction right now. Sponsored by abrdn February 13, 2023
